Methimazole
- Product NDC
- 51293-820
- 11-digit product format
- 512930820
- Labeler code
- 51293
- Product ID
- 51293-820_f141938a-ce0d-4e93-bb2c-53c2461e1d67
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methimazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ECI Pharmaceuticals, LLC
- Application
- ANDA040547
- Marketing category
- ANDA
- Marketing start
- 2016-07-01
- Marketing end
- 0000-00-00
- Substance
- METHIMAZOLE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51293-820 | METHIMAZOLE TABLET [ECI PHARMACEUTICALS, LLC] | 5 | Legacy NDC | 20201228_68942ec1-763a-4757-96ad-0e749aba348c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51293-820-01 | 51293082001 | 100 TABLET in 1 BOTTLE (51293-820-01) | 100 tablet | 2016-07-01 | 0000-00-00 | No | No | Current |